Back to search

Article

Influence of CYP3A4 and CYP3A5 Genetic Variants on Clinical Outcomes in Methylprednisolone-Treated, Hospitalized COVID-19 Patients in Manaus, Brazil

2026-04-09

Abstract excerpt

<h4>Aims: </h4>: This study investigated whether common CYP3A4 and CYP3A5 variants are associated with clinical outcomes in hospitalized COVID-19 patients treated with MP in Manaus, Brazil. <h4>Methods: </h4>: A pharmacogenetic analysis was conducted on 100 hospitalized COVID-19 patients enrolled in a randomized, placebo-controlled clinical trial receiving heavy-dose intravenous MP (n = 49) or placebo (n = 51),...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0477f016-e0c5-5ce6-a913-c3e3f9680672
DOI
10.22541/au.177571298.89733492/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Influence of CYP3A4 and CYP3A5 Genetic Variants on Clinical Outcomes in Methylprednisolone-Treated, Hospitalized COVID-19 Patients in Manaus, BrazilDOI 10.22541/au.177571298.89733492/v1
Select a neighboring publication to make it the new centre.